Concepedia

G. Amaya

GA

Statistics

Publications

2

Citations

252

H-Index

2

Active since

2010

Affiliations

Johnson & Johnson (United States)(Current)

G. Amaya is an author at Johnson & Johnson (United States) specializing in pharmacotherapy, pharmacology, and clinical pharmacology.

Publications per year

2010–2012

2

Publications

2

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Mark H. Wilcox, G. Ralph Corey, George H. Talbot et al. · Journal of Antimicrobial Chemotherapy · 2010 · 215 citations

, , +16

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Mark Nelson, G. Amaya, Nathan Clumeck et al. · Journal of Antimicrobial Chemotherapy · 2012 · 37 citations · Full text

, , +17

1–2 of 2